Published on 7 Feb 2024 on GuruFocus.com via Yahoo Finance
Director Robert Gagnon Sells 9,204 Shares of Verastem Inc (VSTM)
On February 6, 2024, Robert Gagnon, a director at Verastem Inc, executed a sale of 9,204 shares of the company. The transaction was filed with the SEC and can be found in the following SEC Filing.
Warning! GuruFocus has detected 5 Warning Signs with VSTM.
Verastem Inc, traded under the ticker VSTM, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life for cancer patients. The company has a portfolio of product candidates designed to inhibit critical signaling pathways that promote cancer cell survival and proliferation.